BioAlps - Life Sciences Cluster 🇨🇭

🚀 Oculis has announced a $100 million capital increase The financial operation was carried out through an oversubscribed offering of 5 million shares at $20 each. This funding will accelerate the clinical development of Privosegtor (OCS-05), a promising neuroprotective candidate with groundbreaking potential in acute optic neuritis, glaucoma, and beyond. 💡Oculis continues to expand its global impact, with operations in Lausanne, Boston, and Reykjavik. 👁️✨ https://lnkd.in/dgA3RC2H 📸 Oculis #Oculis #Biotech #Ophthalmology #Innovation #Neuroprotection #Healthcare #Investment

🚨 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞 𝐀𝐥𝐞𝐫𝐭: 𝐀𝐩𝐩𝐥𝐲 𝐁𝐞𝐟𝐨𝐫𝐞 𝟏𝟓 𝐅𝐞𝐛𝐫𝐮𝐚𝐫𝐲! Time is running out! There’s just 2 Days left to apply for BioInnovation Day (BIND), happening on 1 April 2025 at Campus Biotech, Geneva. Are you, or someone you know, working on an early-stage #LifeSciences project? Whether it’s in #MedTech, #BioTech, #Pharma, #Digital Health, #Cosmetics, #FoodTech, or related fields, this is your chance to shine! 🎤 What’s in it for you? Secure a #pitch in front of a curated audience of investors, support organisations, and life sciences enthusiasts. It's a unique opportunity to gain visibility, make valuable connections, and propel your project to the next level. 🌟 Don’t miss this chance to showcase your innovation! 👉 Apply now: https://lnkd.in/enJWfnw4 A Huge Thank to our incredible sponsors: Lenz & Staehelin (GOLD) Institut Fédéral de la Propriété Intellectuelle (SILVER) and Innovaud, FONGIT, CSEM, KATZAROV SA - Patent & Trademark Attorneys, reuteler & cie SA (BRONZE). And of course Etat de Genève!

🌟 INSIDE: University of Fribourg 🌟 🎟️: https://lnkd.in/etcwcWDA Join us for an exclusive INSIDE: Université de Fribourg/Universität Freiburg, on 20 March 2025. Through the Unifr – Faculty of Science and Medicine and the Adolphe Merkle Institute, participants will embark on a journey to unlock the brain from lab to life; bridge science and medicine through imaging and translational research; and explore innovation in advancing material science for biomedical applications. Do not miss this incredible opportunity to explore collaborations with one of the key actors of the Swiss Health Valley🇨🇭! 📆 Thursday 20 March 2025, 10.00 am – 1.00 pm 📍 Adolphe Merkle Institute – Chem. des Verdiers 4, 1700 Fribourg 🗣 Language: English ⚠️ Participation is free but registration is mandatory. Promotion économique du canton de Fribourg PromFR,Jerry Krattiger, Barbara Drasler, Ana Claudia Marques, Helene Wigginton, Sandra Ansanay-Alex #lifesciences #events #Neuroscience #biomedical

🌟 What an inspiring DEEP DIVE into cutting-edge surfaces and technologies for enhanced biocompatibility! 🌟 On Tuesday, 11 February 2025, BioAlps and the Laboratory of Advanced Technology (LTA) at Université de Genève hosted a fascinating session exploring the latest advancements in surface functionalization and advanced characterization techniques. 🔬 From innovative material-tissue interfaces to next-generation implants and artificial tissues, our expert speakers shared invaluable insights into how these technologies are shaping the future of biomedicine. 💡 A huge thank you to our incredible speakers: 👏 Dr. Tingting Fu (SIMS scientist, LTA) 👏 Dr. Irena Milosevic (Associate Professor, Haute école du paysage, d'ingénierie et d'architecture de Genève - HEPIA) 👏 Dr. Luigi Bonacina (Associate Professor, UNIGE) 👏 Dr. Jorge Cors (CEO, Phasis) 👏 Erik Poulsen (Medical Market Segment Manager, GF Machining Solutions) And of course Roberto Perez for setting up the event with us ! The engaging panel discussions, insightful Q&A sessions, and dynamic networking opportunities made this event truly unforgettable. We were thrilled to see so many professionals exchanging ideas and forging new collaborations. 🚀 A big thank you to all attendees for making this event a success! Looking forward to continuing these conversations and pushing the boundaries of biocompatibility and medical innovation. #BioAlps #Biocompatibility #MedicalInnovation #SurfaceTechnology #AdvancedMaterials #Networking

🌟 DEEP DIVE - D-1 🌟 Join BioAlps and the 𝐋𝐚𝐛𝐨𝐫𝐚𝐭𝐨𝐫𝐲 𝐨𝐟 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 (LTA) at Université de Genève for an exclusive Deep Dive on 𝘤𝘶𝘵𝘵𝘪𝘯𝘨-𝘦𝘥𝘨𝘦 𝘴𝘶𝘳𝘧𝘢𝘤𝘦𝘴 𝘢𝘯𝘥 𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘪𝘦𝘴 𝘧𝘰𝘳 𝘦𝘯𝘩𝘢𝘯𝘤𝘦𝘥 𝘣𝘪𝘰𝘤𝘰𝘮𝘱𝘢𝘵𝘪𝘣𝘪𝘭𝘪𝘵𝘺. 🗣 SPEAKERS: 🎙 Dr. Tingting Fu, SIMS Scientist, LTA 🎙 Dr. Irena Milosevic, Associate Professor, Haute école du paysage, d'ingénierie et d'architecture de Genève - HEPIA 🎙 Dr. Luigi Bonacina, Associate Professor, UNIGE 🎙 Dr. Jorge Cors, CEO, Phasis 🎙 Erik Poulsen, Medical Market Segment Manager, GF Machining Solutions 📆 11 February 2025 📍UNIGE –  Rue de l'École de Médecine 20, 1205 Genève 🗣 Language: English ⚠️ Registration: Free but mandatory (limited seats). ➡️ Register now: https://lnkd.in/gVRRA3Jr

🌟 What an inspiring BioAlps INSIDE event at Jabil Healthcare – Le Locle! 🌟 Yesterday, we had the privilege of diving into the world of healthcare innovation at Jabil’s impressive facility in the heart of the Swiss Health Valley🇨🇭. Known for its precision engineering and expertise in advanced medical device manufacturing for spine pathologies such as deformities, osteoporosis and thoraco-lumbar fusion. Jabil’s facility in Le Locle is a true gem of innovation. 🔍 From insightful presentations by Jean-Roger Cattin, Operations Director at Jabil, to a fascinating plant tour, the event was an eye-opener to the impactful work happening right here in Switzerland. 🎉 Special thanks to julien mouneyres, Nathalie Boillat, Marc Bello and Gautier Doillon for your help in setting up the event and for the tour. And to Matthieu Aubert, Head of Neuchâtel Economie. 🍸 And, of course, the networking cocktail was the perfect way to connect with peers and exchange ideas about the future of healthcare technology. 👏 Thank you Jabil for hosting the event. The Swiss Health Valley continues to be a hub of excellence, and we are proud to be part of this thriving community!   #SwissHealthValley #HealthcareInnovation #BioAlpsINSIDE #MedTec

Comphya🇨🇭 secures FDA IDE approval for U.S. clinical trial of CaverSTIM! 🇺🇸 The MedTech company from Vaud, has received FDA Investigational Device Exemption (IDE) approval to initiate a U.S. clinical trial for CaverSTIM, the first implantable neuromodulator designed to treat erectile dysfunction (ED). 🗣 Dr. Rodrigo Fraga-Silva, CEO: "This approval underscores CaverSTIM’s potential to address a critical unmet need and reflects our team’s dedication to advancing patient care." The U.S. trial will build on international studies, further validating CaverSTIM’s safety and efficacy. 🔗 https://lnkd.in/dQm4heVX #MedTech #Neuromodulation #ErectileDysfunction #FDAApproval #Innovation

🌟 Five Projects Backed by FIT - Fondation pour l'Innovation et la Technologie. Congratulations to Bio-CapnoMAD (CHUV / Centre hospitalier universitaire vaudois), Helix Robotics (EPFL), MyJoint (EPFL), Neurovia Bioelectronics (EPFL), and Grenat (HEIG-VD) on receiving FIT Tech Grants! From combating sleep apnea and developing human-friendly robotic arms to preventing sports injuries, managing blood pressure, and empowering small farmers with AI, these projects are driving impactful innovation across health, robotics, and agriculture. 👏 Kudos to these teams for pushing boundaries and creating solutions for a better future! ➡️ Learn more: https://lnkd.in/gz7PtsYg #Innovation #TechGrants #HealthTech #AgriTech #Robotics #AI

🚀 Soft robotics meets industrial precision! Helix Robotics, now rebranding as "Embodied AI," is revolutionizing automation with the first commercial soft robot manipulator. Combining the safety of soft robotics with industrial-grade precision, this EPFL spin-off is tackling key challenges in food handling and lab automation. With CHF 150,000 funding from Venture Kick, Helix Robotics is set to grow its business development team and launch a marketing campaign. Led by experts in robotic design and control algorithms, the team is pushing the boundaries of innovation in human-friendly robotics. https://lnkd.in/e5EY5M6h #SoftRobotics #health #Innovation #Automation #EPFL #VentureKick #Startup

🎉 An incredible evening at our Deep Dive on Leadership in #FemTech Innovation! Yesterday, at Campus Biotech in Geneva, we had the privilege of hosting an inspiring event dedicated to advancing FemTech, co-organized by BioAlps and the Healthcare Businesswomen’s Association (HBA) with the support of CSEM. This exclusive session brought together pioneering founders, investors, and industry experts to share insights on the challenges, innovations, and funding landscape in FemTech. ✨ A big thank you to our fantastic speakers: - Samantha Paoletti, Head of Research & Business Development, CSEM - Anna Luisa Schaffgotsch, Founder & CEO, Impli - Giovanna Dipasquale, CEO & Founder, Herosupport SA - Jacqueline Ruedin Rüsch, Founding General Partner, Privilège Ventures - Marco Grisi, Co-Founder & CEO, Annaida Technologies - Wilma Lukas, PhD, MBA Lukas, Senior Advisor & Coach, Innosuisse and FONGIT We were inspired by their stories of leadership and their bold efforts to push the boundaries of FemTech innovation. - Simone Theiss (EPFL Innovation Park & Tech4Eva - The global Femtech accelerator) concluded the evening with a motivating address Thanks to all attendees for making the panel discussion, Q&A session, and networking apéro so engaging! And THANK YOU Alina Favre for your fanstastic job at preparing the session with all the speakers! 💡 Let’s continue working together to foster innovation and equity in healthcare. Stay tuned for more events! #FemTech #Leadership #Innovation #LifeSciences #Networking